Encompass Health Co. (NYSE:EHC) Shares Purchased by Snowden Capital Advisors LLC

Snowden Capital Advisors LLC lifted its stake in Encompass Health Co. (NYSE:EHC) by 6.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 8,307 shares of the company’s stock after acquiring an additional 500 shares during the quarter. Snowden Capital Advisors LLC’s holdings in Encompass Health were worth $767,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. Vanguard Group Inc. lifted its position in Encompass Health by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 10,404,081 shares of the company’s stock worth $960,817,000 after acquiring an additional 138,196 shares in the last quarter. Invesco Ltd. lifted its position in shares of Encompass Health by 3.3% during the fourth quarter. Invesco Ltd. now owns 5,536,251 shares of the company’s stock worth $511,273,000 after purchasing an additional 176,135 shares in the last quarter. Alliancebernstein L.P. boosted its stake in shares of Encompass Health by 6.0% in the fourth quarter. Alliancebernstein L.P. now owns 2,076,869 shares of the company’s stock valued at $191,799,000 after purchasing an additional 117,617 shares during the period. FMR LLC grew its holdings in Encompass Health by 0.8% during the 4th quarter. FMR LLC now owns 1,973,846 shares of the company’s stock valued at $182,285,000 after purchasing an additional 15,831 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in Encompass Health by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 1,679,774 shares of the company’s stock worth $155,176,000 after buying an additional 6,164 shares during the period. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Price Performance

Shares of NYSE EHC opened at $121.15 on Tuesday. The business has a 50 day simple moving average of $105.97 and a 200-day simple moving average of $100.90. Encompass Health Co. has a twelve month low of $82.74 and a twelve month high of $121.44. The company has a market capitalization of $12.21 billion, a price-to-earnings ratio of 27.16, a price-to-earnings-growth ratio of 2.31 and a beta of 0.91. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.18. The business had revenue of $1.46 billion for the quarter, compared to the consensus estimate of $1.43 billion. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The business’s revenue was up 10.6% on a year-over-year basis. During the same quarter last year, the business posted $1.12 EPS. As a group, equities research analysts expect that Encompass Health Co. will post 4.8 earnings per share for the current year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be paid a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.56%. Encompass Health’s payout ratio is 14.05%.

Insider Buying and Selling

In other Encompass Health news, EVP John Patrick Darby sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the completion of the sale, the executive vice president now directly owns 79,710 shares in the company, valued at $9,149,910.90. This represents a 11.15% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total value of $498,974.19. Following the transaction, the insider now owns 11,958 shares in the company, valued at approximately $1,394,422.38. This trade represents a 26.35% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on the stock. Truist Financial reiterated a “buy” rating and issued a $135.00 price objective (up previously from $116.00) on shares of Encompass Health in a report on Monday, April 28th. KeyCorp increased their price target on Encompass Health from $120.00 to $122.00 and gave the company an “overweight” rating in a report on Friday, April 25th. Barclays lifted their price objective on Encompass Health from $118.00 to $129.00 and gave the stock an “overweight” rating in a report on Friday, April 25th. William Blair reaffirmed an “outperform” rating on shares of Encompass Health in a research report on Friday, February 7th. Finally, StockNews.com raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Sunday, May 11th. Nine investment analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $120.86.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.